BioNTech SE
BNTX
$99.47
$2.012.06%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.37B | 138.52M | 203.66M | 1.59B | 974.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.37B | 138.52M | 203.66M | 1.59B | 974.46M |
| Cost of Revenue | 196.68M | 64.36M | 64.16M | 192.82M | 176.11M |
| Gross Profit | 1.17B | 74.16M | 139.50M | 1.40B | 798.36M |
| SG&A Expenses | 165.46M | 197.83M | 143.95M | 136.08M | 167.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 378.41M | 282.32M | -9.23M | 2.05M | 32.33M |
| Total Operating Expenses | 1.35B | 1.17B | 749.81M | 952.99M | 917.43M |
| Operating Income | 22.98M | -1.04B | -546.16M | 639.27M | 57.03M |
| Income Before Tax | 174.47M | -867.31M | -360.20M | 713.99M | 247.51M |
| Income Tax Expenses | -43.32M | 2.15M | -18.13M | 221.02M | 72.71M |
| Earnings from Continuing Operations | 217.79M | -869.46M | -342.07M | 492.97M | 174.80M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 217.79M | -869.46M | -342.07M | 492.97M | 174.80M |
| EBIT | 22.98M | -1.04B | -546.16M | 639.27M | 57.03M |
| EBITDA | 71.79M | -981.51M | -504.58M | 675.45M | 101.99M |
| EPS Basic | 0.90 | -3.62 | -1.42 | 2.06 | 0.73 |
| Normalized Basic EPS | 0.57 | -2.19 | -0.88 | 1.94 | 0.66 |
| EPS Diluted | 0.89 | -3.62 | -1.42 | 2.04 | 0.72 |
| Normalized Diluted EPS | 0.56 | -2.19 | -0.88 | 1.93 | 0.65 |
| Average Basic Shares Outstanding | 241.59M | 240.42M | 240.53M | 239.74M | 239.70M |
| Average Diluted Shares Outstanding | 244.57M | 240.42M | 240.53M | 241.00M | 243.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
